Refractory Acute Myeloid Leukemia Clinical Trials in Memphis, Tennessee
3 recruitingMemphis, Tennessee
Showing 1–3 of 3 trials
Recruiting
Phase 1
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Acute Myeloid LeukemiaRefractory Myelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+2 more
Vanderbilt-Ingram Cancer Center60 enrolled2 locationsNCT06399640
Recruiting
Phase 1
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic Therapy
National Cancer Institute (NCI)47 enrolled7 locationsNCT07012044
Recruiting
Phase 1
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Acute Leukemia of Ambiguous LineageRefractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia
St. Jude Children's Research Hospital24 enrolled10 locationsNCT06177067